Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles
Li Pan,1,2 Zhongwang Zhang,1,2 Jianliang Lv,1,2 Peng Zhou,1,2 Wenfa Hu,1,2 Yuzhen Fang,1,2 Haotai Chen,1,2 Xinsheng Liu,1,2 Junjun Shao,1,2 Furong Zhao,1,2 Yaozhong Ding,1,2 Tong Lin,1,2 Huiyun Chang,1,2 Jie Zhang,1,2 Yongguang Zhang,1,2 Yonglu Wang1,2 1State Key Laboratory of Veterinary Etiologic...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/4608a32c19e849eea8378a208a55c955 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:4608a32c19e849eea8378a208a55c955 |
|---|---|
| record_format |
dspace |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Pan L Zhang ZW Lv JL Zhou P Hu WF Fang YZ Chen HT Liu XS Shao JJ Zhao FR Ding YZ Lin T Chang HY Zhang J Zhang YG Wang YL Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles |
| description |
Li Pan,1,2 Zhongwang Zhang,1,2 Jianliang Lv,1,2 Peng Zhou,1,2 Wenfa Hu,1,2 Yuzhen Fang,1,2 Haotai Chen,1,2 Xinsheng Liu,1,2 Junjun Shao,1,2 Furong Zhao,1,2 Yaozhong Ding,1,2 Tong Lin,1,2 Huiyun Chang,1,2 Jie Zhang,1,2 Yongguang Zhang,1,2 Yonglu Wang1,2 1State Key Laboratory of Veterinary Etiological Biology, National Foot-and-Mouth Disease Reference Laboratory, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (CAAS), Lanzhou, Gansu, People’s Republic of China; 2Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, People’s Republic of China Abstract: The aim of this study was to enhance specific mucosal, systemic, and cell-mediated immunity and to induce earlier onset of protection against direct-contact challenge in cattle by intranasal delivery of a nanoparticle-based nasal vaccine against type A foot-and-mouth disease (FMD). In this study, two kinds of nanoparticle-based nasal vaccines against type A FMD were designed: (1) chitosan-coated poly(lactic-co-glycolic acid) (PLGA) loaded with plasmid DNA (Chi-PLGA-DNA) and (2) chitosan-trehalose and inactivated foot-and-mouth disease virus (FMDV) (Chi-Tre-Inactivated). Cattle were immunized by an intranasal route with nanoparticles and then challenged for 48 hours by direct contact with two infected donor cattle per pen. Donors were inoculated intradermally in the tongue 48 hours before challenge, with 0.2 mL cattle-passaged FMDV. Serological and mucosal antibody responses were evaluated, and virus excretion and the number of contact infections were quantified. FMDV-specific secretory immunoglobulin (Ig)A (sIgA) antibodies in nasal washes were initially detected at 4 days postvaccination (dpv) with two kinds of nanoparticles. The highest levels of sIgA expression were observed in nasal washes, at 10 dpv, from animals with Chi-PLGA-DNA nanoparticles, followed by animals immunized once by intranasal route with a double dose of Chi-Tre-Inactivated nanoparticles and animals immunized by intranasal route three times with Chi-Tre-Inactivated nanoparticles (P<0.05). FMDV-specific IgA antibodies in serum showed a similar pattern. All animals immunized by intranasal route developed low levels of detectable IgG in serum at 10 dpv. Following stimulation with FMDV, the highest levels of proliferation were observed in splenocytes harvested from Chi-PLGA-DNA-immunized animals, followed by proliferation of cells harvested from Chi-Tre-Inactivated nanoparticle-immunized animals (P<0.05). Higher protection rates were associated with the highest sIgA antibody responses induced in the Chi-PLGA-DNA nanoparticle-immunized group. Only one animal was clinically affected with mild signs after 7 days of contact challenge, after a delay of 2–3 days compared with the clinically affected negative-control group. Of the five animals directly challenged that were vaccinated by intranasal route with a double dose of Chi-Tre-Inactivated, four were clinically infected; however, the degree of severity of disease in this group was lower than in control cattle. The number of viral RNA copies in nasal swabs from the vaccinated, severely infected group was significantly higher than in swabs from the vaccinated, clinically protected group. These data suggested that intranasal delivery of Chi-PLGA-DNA nanoparticles resulted in higher levels of mucosal, systemic, and cell-mediated immunity than did of Chi-Tre-Inactivated nanoparticles. In conclusion, although intranasal delivery with FMDV antigen mediated by nanoparticles did not provide complete clinical protection, it reduced disease severity and virus excretion and delayed clinical symptoms. Chi-PLGA-DNA nanoparticle vaccines have potential as a nasal delivery system for vaccines. Keywords: FMDV, nanoparticles, chitosan, trehalose, poly(lactic-co-glycolic acid), PLGA |
| format |
article |
| author |
Pan L Zhang ZW Lv JL Zhou P Hu WF Fang YZ Chen HT Liu XS Shao JJ Zhao FR Ding YZ Lin T Chang HY Zhang J Zhang YG Wang YL |
| author_facet |
Pan L Zhang ZW Lv JL Zhou P Hu WF Fang YZ Chen HT Liu XS Shao JJ Zhao FR Ding YZ Lin T Chang HY Zhang J Zhang YG Wang YL |
| author_sort |
Pan L |
| title |
Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles |
| title_short |
Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles |
| title_full |
Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles |
| title_fullStr |
Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles |
| title_full_unstemmed |
Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles |
| title_sort |
induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles |
| publisher |
Dove Medical Press |
| publishDate |
2014 |
| url |
https://doaj.org/article/4608a32c19e849eea8378a208a55c955 |
| work_keys_str_mv |
AT panl inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT zhangzw inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT lvjl inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT zhoup inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT huwf inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT fangyz inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT chenht inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT liuxs inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT shaojj inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT zhaofr inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT dingyz inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT lint inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT changhy inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT zhangj inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT zhangyg inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles AT wangyl inductionofmucosalimmuneresponsesandprotectionofcattleagainstdirectcontactchallengebyintranasaldeliverywithfootandmouthdiseasevirusantigenmediatedbynanoparticles |
| _version_ |
1718403551175114752 |
| spelling |
oai:doaj.org-article:4608a32c19e849eea8378a208a55c9552021-12-02T00:40:51ZInduction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles1178-2013https://doaj.org/article/4608a32c19e849eea8378a208a55c9552014-12-01T00:00:00Zhttp://www.dovepress.com/induction-of-mucosal-immune-responses-and-protection-of-cattle-against-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013 Li Pan,1,2 Zhongwang Zhang,1,2 Jianliang Lv,1,2 Peng Zhou,1,2 Wenfa Hu,1,2 Yuzhen Fang,1,2 Haotai Chen,1,2 Xinsheng Liu,1,2 Junjun Shao,1,2 Furong Zhao,1,2 Yaozhong Ding,1,2 Tong Lin,1,2 Huiyun Chang,1,2 Jie Zhang,1,2 Yongguang Zhang,1,2 Yonglu Wang1,2 1State Key Laboratory of Veterinary Etiological Biology, National Foot-and-Mouth Disease Reference Laboratory, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (CAAS), Lanzhou, Gansu, People’s Republic of China; 2Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, People’s Republic of China Abstract: The aim of this study was to enhance specific mucosal, systemic, and cell-mediated immunity and to induce earlier onset of protection against direct-contact challenge in cattle by intranasal delivery of a nanoparticle-based nasal vaccine against type A foot-and-mouth disease (FMD). In this study, two kinds of nanoparticle-based nasal vaccines against type A FMD were designed: (1) chitosan-coated poly(lactic-co-glycolic acid) (PLGA) loaded with plasmid DNA (Chi-PLGA-DNA) and (2) chitosan-trehalose and inactivated foot-and-mouth disease virus (FMDV) (Chi-Tre-Inactivated). Cattle were immunized by an intranasal route with nanoparticles and then challenged for 48 hours by direct contact with two infected donor cattle per pen. Donors were inoculated intradermally in the tongue 48 hours before challenge, with 0.2 mL cattle-passaged FMDV. Serological and mucosal antibody responses were evaluated, and virus excretion and the number of contact infections were quantified. FMDV-specific secretory immunoglobulin (Ig)A (sIgA) antibodies in nasal washes were initially detected at 4 days postvaccination (dpv) with two kinds of nanoparticles. The highest levels of sIgA expression were observed in nasal washes, at 10 dpv, from animals with Chi-PLGA-DNA nanoparticles, followed by animals immunized once by intranasal route with a double dose of Chi-Tre-Inactivated nanoparticles and animals immunized by intranasal route three times with Chi-Tre-Inactivated nanoparticles (P<0.05). FMDV-specific IgA antibodies in serum showed a similar pattern. All animals immunized by intranasal route developed low levels of detectable IgG in serum at 10 dpv. Following stimulation with FMDV, the highest levels of proliferation were observed in splenocytes harvested from Chi-PLGA-DNA-immunized animals, followed by proliferation of cells harvested from Chi-Tre-Inactivated nanoparticle-immunized animals (P<0.05). Higher protection rates were associated with the highest sIgA antibody responses induced in the Chi-PLGA-DNA nanoparticle-immunized group. Only one animal was clinically affected with mild signs after 7 days of contact challenge, after a delay of 2–3 days compared with the clinically affected negative-control group. Of the five animals directly challenged that were vaccinated by intranasal route with a double dose of Chi-Tre-Inactivated, four were clinically infected; however, the degree of severity of disease in this group was lower than in control cattle. The number of viral RNA copies in nasal swabs from the vaccinated, severely infected group was significantly higher than in swabs from the vaccinated, clinically protected group. These data suggested that intranasal delivery of Chi-PLGA-DNA nanoparticles resulted in higher levels of mucosal, systemic, and cell-mediated immunity than did of Chi-Tre-Inactivated nanoparticles. In conclusion, although intranasal delivery with FMDV antigen mediated by nanoparticles did not provide complete clinical protection, it reduced disease severity and virus excretion and delayed clinical symptoms. Chi-PLGA-DNA nanoparticle vaccines have potential as a nasal delivery system for vaccines. Keywords: FMDV, nanoparticles, chitosan, trehalose, poly(lactic-co-glycolic acid), PLGAPan LZhang ZWLv JLZhou PHu WFFang YZChen HTLiu XSShao JJZhao FRDing YZLin TChang HYZhang JZhang YGWang YLDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 5603-5618 (2014) |